Three Attorneys General Challenge FDA Approval of New Generic Abortion Pill

The Missouri attorney general’s office accused the FDA of approving the new version of mifepristone without requiring new safety studies.

Boxes of mifepristone, the first pill taken in a medical abortion, at Alamo Women's Clinic in Carbondale, Ill., on April 9, 2024. Evelyn Hockstein/Reuters

Attorneys general from three states have filed a new challenge in their lawsuit to restrict access to the abortion pill mifepristone in their states to encompass the U.S. Food and Drug Administration’s recent approval of a new generic version of the pill.

Missouri Attorney General Catherine Hanaway said on Nov. 20 that she had filed a new challenge against the FDA’s Sept. 30 approval of the new pill. She is joined by fellow plaintiffs Idaho Attorney General Raúl Labrador and Kansas Attorney General Kris Kobach.